BioCentury
ARTICLE | Company News

Asahi Kasei, Zoll Medical deal

March 19, 2012 7:00 AM UTC

Asahi will acquire Zoll for $93 per share in cash, or about $2.2 billion. The price is a 24% premium to Zoll's close of $75.10 on March 9, before the deal was announced. Any shares not purchased in the cash tender offer will be acquired for the same price in a second-step merger. Following the deal, which is expected to close next quarter, Zoll will become a wholly-owned subsidiary of Asahi Kasei. ...